naphazoline has been researched along with Conjunctival Diseases in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasquali, TA | 1 |
| Aufderheide, A | 1 |
| Brinton, JP | 1 |
| Avila, MR | 1 |
| Stahl, ED | 1 |
| Durrie, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect if Brimonidine 0.15% on the Development of Subconjunctival Hemorrhage Following Femtosecond Laser Assisted Cataract Surgery[NCT04633954] | 56 participants (Actual) | Interventional | 2019-06-06 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for naphazoline and Conjunctival Diseases
| Article | Year |
|---|---|
Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Conjun | 2013 |